Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
38.65
-0.46 (-1.18%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bright Minds Biosciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for DRUG stock has a target of 75, which predicts an increase of 94.05% from the current stock price of 38.65.
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for DRUG is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 |
|---|---|
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Initiates $75 | Buy | Initiates | $75 | +94.05% | Nov 25, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.